RIGL Competitors & Alternatives
Compare Rigel Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RIGL
Main Stock$28.74
Tradestie Score
60
Market Cap
$505.12M
P/E Ratio
1.7
Revenue Growth
0.1%
Analyst Upside
+85.1%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.57
|
$665.30M | - | 55 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$10.34
|
$626.91M | - | 50 | Compare |
|
SVRA
Savara Inc.
|
$5.14
|
$611.84M | - | 57 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$26.75
|
$608.81M | - | 62 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.56
|
$552.46M | - | 45 | Compare |
|
VSTM
Verastem, Inc.
|
$4.32
|
$541.60M | - | 53 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.61
|
$540.97M | - | 45 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$10.02
|
$533.99M | - | 56 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.87
|
$529.35M | 5.8 | 63 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.17
|
$512.39M | - | 60 | Compare |
More RIGL Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry